On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

As former “Health and Wellness” columnist Sharon Gerdes wrote in her September column, one such ingredient that could be beneficial is Palatinose, Beneo’s patented isomaultulose, which can be used in ...

The surging popularity of GLP-1 drugs is beginning to obscure the health consequences if people stop taking them, physicians ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...